These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
375 related articles for article (PubMed ID: 18091382)
1. Coexpression of c-kit and bcl-2 in small cell carcinoma and large cell neuroendocrine carcinoma of the lung. LaPoint RJ; Bourne PA; Wang HL; Xu H Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):401-6. PubMed ID: 18091382 [TBL] [Abstract][Full Text] [Related]
2. Frequent overexpression of the c-kit protein in large cell neuroendocrine carcinoma of the lung. Araki K; Ishii G; Yokose T; Nagai K; Funai K; Kodama K; Nishiwaki Y; Ochiai A Lung Cancer; 2003 May; 40(2):173-80. PubMed ID: 12711118 [TBL] [Abstract][Full Text] [Related]
3. Large cell neuroendocrine carcinoma of the lung: a histologic and immunohistochemical study of 22 cases. Jiang SX; Kameya T; Shoji M; Dobashi Y; Shinada J; Yoshimura H Am J Surg Pathol; 1998 May; 22(5):526-37. PubMed ID: 9591721 [TBL] [Abstract][Full Text] [Related]
4. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome. Przygodzki RM; Finkelstein SD; Langer JC; Swalsky PA; Fishback N; Bakker A; Guinee DG; Koss M; Travis WD Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922 [TBL] [Abstract][Full Text] [Related]
5. Expression profiling of receptor tyrosine kinases in high-grade neuroendocrine carcinoma of the lung: a comparative analysis with adenocarcinoma and squamous cell carcinoma. Matsumura Y; Umemura S; Ishii G; Tsuta K; Matsumoto S; Aokage K; Hishida T; Yoshida J; Ohe Y; Suzuki H; Ochiai A; Goto K; Nagai K; Tsuchihara K J Cancer Res Clin Oncol; 2015 Dec; 141(12):2159-70. PubMed ID: 25989941 [TBL] [Abstract][Full Text] [Related]
6. Gene product immunophenotyping of neuroendocrine lung tumors. No linking evidence between carcinoids and small-cell lung carcinomas suggested by multivariate statistical analysis. Sampietro G; Tomasic G; Collini P; Biganzoli E; Boracchi P; Bidoli P; Pilotti S Appl Immunohistochem Mol Morphol; 2000 Mar; 8(1):49-56. PubMed ID: 10937049 [TBL] [Abstract][Full Text] [Related]
7. High-grade neuroendocrine carcinoma of the lung: comparative clinicopathological study of large cell neuroendocrine carcinoma and small cell lung carcinoma. Sun L; Sakurai S; Sano T; Hironaka M; Kawashima O; Nakajima T Pathol Int; 2009 Aug; 59(8):522-9. PubMed ID: 19627535 [TBL] [Abstract][Full Text] [Related]
8. The significance of frequent and independent p53 and bcl-2 expression in large-cell neuroendocrine carcinomas of the lung. Jiang SX; Kameya T; Shinada J; Yoshimura H Mod Pathol; 1999 Apr; 12(4):362-9. PubMed ID: 10229500 [TBL] [Abstract][Full Text] [Related]
10. Bcl-2, p53, CD44, and CD44v6 isoform expression in neuroendocrine tumors of the lung. Coppola D; Clarke M; Landreneau R; Weyant RJ; Cooper D; Yousem SA Mod Pathol; 1996 May; 9(5):484-90. PubMed ID: 8733762 [TBL] [Abstract][Full Text] [Related]
11. hASH1 is a specific immunohistochemical marker for lung neuroendocrine tumors. Ye B; Cappel J; Findeis-Hosey J; McMahon L; Yang Q; Xiao GQ; Xu H; Li F Hum Pathol; 2016 Feb; 48():142-7. PubMed ID: 26596584 [TBL] [Abstract][Full Text] [Related]
12. Bcl-2 protein expression in lung cancer and close correlation with neuroendocrine differentiation. Jiang SX; Kameya T; Sato Y; Yanase N; Yoshimura H; Kodama T Am J Pathol; 1996 Mar; 148(3):837-46. PubMed ID: 8774138 [TBL] [Abstract][Full Text] [Related]
13. High-grade neuroendocrine carcinomas of the lung express K homology domain containing protein overexpressed in cancer but carcinoid tumors do not. Xu H; Bourne PA; Spaulding BO; Wang HL Hum Pathol; 2007 Apr; 38(4):555-63. PubMed ID: 17316760 [TBL] [Abstract][Full Text] [Related]
14. Differential retinoblastoma and p16(INK4A) protein expression in neuroendocrine tumors of the lung. Dosaka-Akita H; Cagle PT; Hiroumi H; Fujita M; Yamashita M; Sharma A; Kawakami Y; Benedict WF Cancer; 2000 Feb; 88(3):550-6. PubMed ID: 10649246 [TBL] [Abstract][Full Text] [Related]
16. Kit expression in small cell carcinomas of the lung: effects of chemotherapy. Rossi G; Cavazza A; Marchioni A; Migaldi M; Bavieri M; Facciolongo N; Petruzzelli S; Longo L; Tamberi S; Crinò L Mod Pathol; 2003 Oct; 16(10):1041-7. PubMed ID: 14559988 [TBL] [Abstract][Full Text] [Related]
17. Molecular markers for reinforcement of histological subclassification of neuroendocrine lung tumors. Kobayashi Y; Tokuchi Y; Hashimoto T; Hayashi M; Nishimura H; Ishikawa Y; Nakagawa K; Sato Y; Takahashi A; Tsuchiya E Cancer Sci; 2004 Apr; 95(4):334-41. PubMed ID: 15072592 [TBL] [Abstract][Full Text] [Related]
18. [Clinicopathological significance of expression of c-kit protein in neuroendocrine lung carcinoma]. Zhao P; Hou N; Shao Y; Li XH Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(22):1526-9. PubMed ID: 16179109 [TBL] [Abstract][Full Text] [Related]
19. PAX-5 expression in pulmonary neuroendocrine neoplasms: its usefulness in surgical and fine-needle aspiration biopsy specimens. Sica G; Vazquez MF; Altorki N; Port J; Lee PC; Liu Y; Hyjek E; Saqi A Am J Clin Pathol; 2008 Apr; 129(4):556-62. PubMed ID: 18343782 [TBL] [Abstract][Full Text] [Related]
20. Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities. Swarts DR; Ramaekers FC; Speel EJ Biochim Biophys Acta; 2012 Dec; 1826(2):255-71. PubMed ID: 22579738 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]